logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10125144 B1

PDFFull Text
Date of Patent:
Nov. 13, 2018

Filed:

Oct. 07, 2014

Rho kinase inhibitors

Applicant:

Kadmon Corporation, Llc, New York, NY (US);

Inventors:

Ji-in Kim, Princeton, NJ (US);

Kevin Liu, West Windsor, NJ (US);

Masha Poyurovsky, New York, NY (US);

Dan Lu, Montvale, NJ (US);

Zhenping Zhu, Woodcliff Lake, NJ (US);

Assignee:

KADMON CORPORATION, LLC, New York, NY (US);

Attorney:

Fox Rothschild LLP

Primary Examiner:

Deepak R Rao

Int. Cl.
CPC ...
C07D 403/14 (2006.01); C07D 495/04 (2006.01); C07D 401/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 491/048 (2006.01); C07D 491/052 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 39/3955 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/048 (2013.01); C07D 491/052 (2013.01); C07K 16/2863 (2013.01); C07K 2317/76 (2013.01);
Abstract

The invention provides novel inhibitors of ROCK1 and/or ROCK2. Also provided are methods of treating diseases and disorders involving inhibiting ROCK1 and/or ROCK2. The present invention includes pharmaceutical compositions comprising the compounds of the invention and a pharmaceutically acceptable carrier and/or diluents. The present invention includes compositions comprising a substantially pure compound of the invention and a pharmaceutically acceptable salt, steroisomer, or hydrate thereof: and a pharmaceutically acceptable excipient and/or diluents.

Find Patent Forward Citations

Kim, Ji-in. (2018). Rho kinase inhibitors (U.S. Patent No. 10125144). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10125144

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…